The bronchodilator effect of a new adrenergic aerosol--Salmefamol.
D000336:Aerosols; D000605:Amino Alcohols / Q000008:administration & dosage* / Q000494:pharmacology; D001249:Asthma / Q000188:drug therapy*; D001980:Bronchi / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000494:pharmacology; D004106:Dilatation; D004837:Epinephrine / Q000008:administration & dosage; D000431:Ethanol / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D009921:Metaproterenol / Q000008:administration & dosage; D010627:Phenethylamines / Q000008:administration & dosage* / Q000494:pharmacology; D010919:Placebos; D012119:Respiration / Q000187:drug effects; D013147:Spirometry; D013566:Sympathomimetics / Q000008:administration & dosage* / Q000494:pharmacology; D013997:Time Factors
D000336:Aerosols; D000605:Amino Alcohols; D001993:Bronchodilator Agents; D010627:Phenethylamines; D010919:Placebos; D013566:Sympathomimetics; D000431:Ethanol; D009921:Metaproterenol; D004837:Epinephrine